MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    CVT-301 (levodopa inhalation powder) improves Patient Global Impression of Change (PGIC) over 1 year in patients with Parkinson’s disease (PD): a meta-analysis

    M. Saint-Hilaire, A. Corbin, P. Zhao, D. Kegler-Ebo (Boston, USA)

    Objective: A meta-analysis of PGIC results was performed using combined data from 3 different studies of CVT-301 in patients with PD over a total of…
  • MDS Virtual Congress 2021

    Effect of oxytocin on response inhibition in Parkinson´s disease: a pilot study

    F. Carbone, P. Ellmerer, S. Spielberger, M. Peball, V. Sidoroff, M. Ritter, K. Seppi, W. Poewe, A. Djamshidian (Innsbruck, Austria)

    Objective: To observe the effect of oxytocin (OXT) on response inhibition in Parkinson´s disease (PD) patients using dedicated saccadic tasks. Background: Cumulating evidence has shown…
  • MDS Virtual Congress 2021

    Effectiveness of opicapone in Parkinson’s disease patients with motor fluctuations according to baseline use of entacapone: findings from the real-world OPTIPARK study

    W. Jost, H. Reichmann, A. Lees, D. Marinho, D. Magalhães, J. Rocha, P. Soares-da-Silva (Wolfach, Germany)

    Objective: This post-hoc analysis evaluated the effectiveness of opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuations (MF) according to baseline use of entacapone…
  • MDS Virtual Congress 2021

    Associations between Exercise Classes and Self-Reported Exercise by People with Parkinson’s Disease at Parkinson’s Foundation Centers of Excellence

    E. Nettnin, S. Burrows, D. Simon, S. Wu, G. Miao, M. Rafferty (Chicago, USA)

    Objective: We sought to examine the relationship between the characteristics of Parkinson’s Foundation Center of Excellence (COE)-based and community-based exercise classes and the self-reported hours…
  • MDS Virtual Congress 2021

    The effectiveness of home modification on gait and falling episode in Parkinson’s disease (PD) patients.

    J. Sringean, S. Phumphid, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)

    Objective: Identify the unsafe PD patients’ home who had gait problems and provide home modifications. Background: The motor impairments in PD also involve both appendicular…
  • MDS Virtual Congress 2021

    TELEMONITORING OF THE ORAL HEALTH OF PARKINSONIANS DURING THE NEW CORONAVIRUS PANDEMIC

    C. da Silva, J. de Oliveira, N. Filho, T. da Silva, V. Marques, G. Monteiro, R. Tavares, M. Borges Andrade, A. Sobral, C. Accioly Lins (Recife, Brazil)

    Objective: To Promote telemonitoring of the oral health of people with Parkinson disease in times of Covid-19. Background: Among the most affected population by Covid-19…
  • MDS Virtual Congress 2021

    “Striatal Hand Signs” and early diagnosis of Parkinson’s Disease: The “Monkey-Wrench Sign”.

    I. Teixeira, V. Souza, C. Zorzenon, B. Veiga, V. Borges, H. Ferraz (São Paulo, Brazil)

    Objective: To identify signs of hand deformations in PD patients with earlier diseases, and compare with intermediate and late phases patients. Background: “Striatal hand signs”,…
  • MDS Virtual Congress 2021

    Central and Peripheral neurological manifestations of COVID-19 in a cohort of patients with Parkinson’s disease.

    A. Vaish, B. Tyson, S. Ray (Redmond, USA)

    Objective: To describe central and peripheral neurological manifestations in patients with COVID-19 and Parkinson’s disease. Background: COVID-19 is associated with central and peripheral neurological manifestations.…
  • MDS Virtual Congress 2021

    Reduced Alpha suppression & altered EEG signal complexity in Parkinson’s disease – signatures of cognitive impairment?

    S M. Keller, A. Meyer, U. Gschwandtner, S M. Beltrani, K. Toloraia, P. Fuhr (Basel, Switzerland)

    Objective: In a cross-sectional setting both alpha suppression and complexity of alpha-band oscillations are evaluated as diagnostic biomarker for assessing MCI in early stages of…
  • MDS Virtual Congress 2021

    Facial emotion recognition and social behavioral problems in de novo parkinson’s disease patients

    A. Slomp, S. Vander Zee, J. Boertien, M. Gerritsen, T. van Laar, J. Spikman (Groningen, Netherlands)

    Objective: To examine facial emotion recognition (FER) as crucial component of social cognition and its relationship with social-behavioral problems in de novo drug-naïve Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 383
  • 384
  • 385
  • 386
  • 387
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley